Steris | STE - Sales Revenues

Stock Price
263.97
Daily Change
1.37 0.52%
Monthly
4.12%
Yearly
19.63%
Q1 Forecast
254.51

Steris reported $1.03B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
3M USD 6.1B 200M Dec/2025
Avanos Medical USD 177.8M 2.8M Sep/2025
Baxter International USD 2.84B 30M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Boston Scientific USD 5.07B 10M Sep/2025
CONMED USD 373.2M 35.3M Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Dexcom USD 1.21B 50M Sep/2025
Ecolab USD 4.17B 150M Sep/2025
Edwards Lifesciences USD 1.55B 20M Sep/2025
Fortive USD 1.03B 488.8M Sep/2025
Getinge SEK 11.07B 3.2B Dec/2024
Globus Medical USD 769M 23.7M Sep/2025
Haemonetics USD 327M 5.61M Sep/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Olympus JPY 247.84B 41.33B Sep/2025
Owens Minor USD 697.26M 15.36M Sep/2025
ResMed USD 1.4B 100M Dec/2025
Steris USD 1.03B 360M Sep/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 249.25M 8.57M Sep/2025
Teleflex USD 913M 132.11M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025